ArticleDiscover oncology2024

UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathway.

Siyuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.